CA2084290A1 - Inhibition des maladies liees aux voies de la 5-lipoxygenase et de la cyclooxygenase - Google Patents
Inhibition des maladies liees aux voies de la 5-lipoxygenase et de la cyclooxygenaseInfo
- Publication number
- CA2084290A1 CA2084290A1 CA002084290A CA2084290A CA2084290A1 CA 2084290 A1 CA2084290 A1 CA 2084290A1 CA 002084290 A CA002084290 A CA 002084290A CA 2084290 A CA2084290 A CA 2084290A CA 2084290 A1 CA2084290 A1 CA 2084290A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- alkenyl
- pyridyl
- formula
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53719590A | 1990-06-12 | 1990-06-12 | |
US537,195 | 1990-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2084290A1 true CA2084290A1 (fr) | 1991-12-13 |
Family
ID=24141624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002084290A Abandoned CA2084290A1 (fr) | 1990-06-12 | 1991-06-07 | Inhibition des maladies liees aux voies de la 5-lipoxygenase et de la cyclooxygenase |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0533837A4 (fr) |
JP (1) | JPH05508153A (fr) |
KR (1) | KR930700104A (fr) |
AU (1) | AU8205991A (fr) |
CA (1) | CA2084290A1 (fr) |
IE (1) | IE911977A1 (fr) |
NZ (1) | NZ238485A (fr) |
PT (1) | PT97960A (fr) |
WO (1) | WO1991019497A1 (fr) |
ZA (1) | ZA914491B (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0679396A1 (fr) * | 1994-03-02 | 1995-11-02 | Pfizer Inc. | Utilisation de dérivés oxindol-2-carboxamides-1,3-substitués pour la fabrication d'un médicament destiné au traiter des dommages du myocardes causés par une ischémie et les dommages du myocardes induits par les cytokines |
US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
JPH11507670A (ja) * | 1995-06-12 | 1999-07-06 | ジー.ディー.サール アンド カンパニー | シクロオキシゲナーゼ−2インヒビターと5−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療 |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
WO1999012930A1 (fr) | 1997-09-05 | 1999-03-18 | Glaxo Group Limited | Derives de 2,3-diaryl-pyrazolo[1,5-b]pyridazine, leur preparation et leur utilisation en tant qu'inhibiteurs de cyclooxygenase 2 (cox-2) |
JP2001526230A (ja) | 1997-12-19 | 2001-12-18 | スミスクライン・ビーチャム・コーポレイション | ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用 |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
ATE266399T1 (de) | 1998-08-20 | 2004-05-15 | Smithkline Beecham Corp | Neue substituierte triazolverbindungen |
BR9915011A (pt) | 1998-11-03 | 2001-08-07 | Glaxo Group Ltd | Compostos, método para a preparação dos mesmos, composição farmacêutica, métodos de tratamento de um indivìduo humano ou animal sofrendo de uma condição que é mediada pela inibição seletiva de cox-2 e sofrendo de um distúrbio inflamatório, e, uso de um composto |
AU1909200A (en) | 1998-11-04 | 2000-05-22 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
JP2002538157A (ja) | 1999-02-27 | 2002-11-12 | グラクソ グループ リミテッド | ピラゾロピリジン |
CN1255406C (zh) | 1999-11-10 | 2006-05-10 | 奥索-麦克尼尔药品公司 | 取代的2-芳基-3-(杂芳基)-咪唑并[1,2-a]嘧啶类化合物以及相关的药物组合物和方法 |
ATE296809T1 (de) | 1999-11-23 | 2005-06-15 | Smithkline Beecham Corp | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren |
EP1233950B1 (fr) | 1999-11-23 | 2005-10-05 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-ones comme inhibiteurs de csbp/p38 kinase |
US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
WO2001038312A1 (fr) | 1999-11-23 | 2001-05-31 | Smithkline Beecham Corporation | COMPOSES DE 3,4-DIHYDRO-(1H)QUINAZOLINE-2-ONE UTILISES COMME INHIBITEURS DE LA KINASE CSBP/p38 |
GB9930358D0 (en) | 1999-12-22 | 2000-02-09 | Glaxo Group Ltd | Process for the preparation of chemical compounds |
US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
AU2002239348A1 (en) | 2000-12-15 | 2002-06-24 | Glaxo Group Limited | Pyrazolopyridine derivatives |
JP2004518651A (ja) | 2000-12-15 | 2004-06-24 | グラクソ グループ リミテッド | 治療用化合物 |
DE60201074T2 (de) | 2001-03-08 | 2005-09-15 | Smithkline Beecham Corp. | Pyrazolopyridinderivate |
US6596731B2 (en) | 2001-03-27 | 2003-07-22 | Hoffmann-La Roche Inc. | Substituted imidazo[1,2-A] pyridine derivatives |
JP4237497B2 (ja) | 2001-03-30 | 2009-03-11 | スミスクライン ビーチャム コーポレーション | ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用 |
EP1377575B1 (fr) | 2001-04-10 | 2006-07-05 | SmithKline Beecham Corporation | Composes de pyrazolopyridine antiviraux |
US6756498B2 (en) | 2001-04-27 | 2004-06-29 | Smithkline Beecham Corporation | Process for the preparation of chemical compounds |
EP1385847B1 (fr) | 2001-04-27 | 2005-06-01 | SmithKline Beecham Corporation | Derives de pyrazolo (1,5-a) pyridine |
ES2271273T3 (es) * | 2001-06-21 | 2007-04-16 | Smithkline Beecham Corporation | Derivados imidazo-1,2-aipiridina para la profilaxis y tratamiento de las infecciones del virus del herpres. |
US7244740B2 (en) | 2001-10-05 | 2007-07-17 | Smithkline Beecham Corporation | Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
DE60222465T2 (de) | 2001-12-11 | 2008-06-05 | Smithkline Beecham Corp. | Pyrazolopyridin-derivate als antiherpesmittel |
EP1546148A1 (fr) | 2002-10-03 | 2005-06-29 | SmithKline Beecham Corporation | Composes therapeutiques a base de derives de pyrazolopyridine |
CA2620223A1 (fr) | 2005-09-02 | 2007-03-08 | Abbott Laboratories | Nouveaux heterocycles a base imidazo |
EP2170337A4 (fr) | 2007-06-28 | 2013-12-18 | Abbvie Inc | Nouvelles triazolopyridazines |
US20120220581A1 (en) | 2009-10-30 | 2012-08-30 | Janssen-Cilag, S.A. | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
KR101692126B1 (ko) | 2009-12-18 | 2017-01-02 | 미쓰비시 타나베 파마 코퍼레이션 | 신규 항혈소판약 |
AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
US9173887B2 (en) | 2010-12-22 | 2015-11-03 | Abbvie Inc. | Hepatitis C inhibitors and uses thereof |
CA2838645C (fr) | 2011-06-27 | 2020-03-10 | Janssen Pharmaceutica Nv | Derives de 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline |
US9669035B2 (en) | 2012-06-26 | 2017-06-06 | Janssen Pharmaceutica Nv | Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders |
ES2607184T3 (es) | 2012-07-09 | 2017-03-29 | Janssen Pharmaceutica, N.V. | Inhibidores de la enzima fosfodiesterasa 10 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002941A (en) * | 1985-12-12 | 1991-03-26 | Smithkline Beecham Corporation | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
ZW24186A1 (en) * | 1985-12-12 | 1987-07-08 | Smithkline Beckman Corp | Inhibition of the 5-lipoxygenase pathway |
CA2060309A1 (fr) * | 1989-06-13 | 1990-12-14 | Alison M. Badger | Inhibition de la production d'interleukine-1 et de facteur de necrose tumorale par les monocytes et (ou) les macrophages |
-
1991
- 1991-06-07 AU AU82059/91A patent/AU8205991A/en not_active Abandoned
- 1991-06-07 WO PCT/US1991/004022 patent/WO1991019497A1/fr not_active Application Discontinuation
- 1991-06-07 JP JP91512077A patent/JPH05508153A/ja active Pending
- 1991-06-07 KR KR1019920703188A patent/KR930700104A/ko not_active Application Discontinuation
- 1991-06-07 EP EP19910912750 patent/EP0533837A4/en not_active Withdrawn
- 1991-06-07 CA CA002084290A patent/CA2084290A1/fr not_active Abandoned
- 1991-06-10 ZA ZA914491A patent/ZA914491B/xx unknown
- 1991-06-11 NZ NZ238485A patent/NZ238485A/en unknown
- 1991-06-11 IE IE197791A patent/IE911977A1/en unknown
- 1991-06-12 PT PT97960A patent/PT97960A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA914491B (en) | 1992-12-30 |
IE911977A1 (en) | 1991-12-18 |
AU8205991A (en) | 1992-01-07 |
PT97960A (pt) | 1992-03-31 |
NZ238485A (en) | 1994-03-25 |
EP0533837A4 (en) | 1994-11-17 |
EP0533837A1 (fr) | 1993-03-31 |
KR930700104A (ko) | 1993-03-13 |
JPH05508153A (ja) | 1993-11-18 |
WO1991019497A1 (fr) | 1991-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2084290A1 (fr) | Inhibition des maladies liees aux voies de la 5-lipoxygenase et de la cyclooxygenase | |
JP6132410B2 (ja) | ホスファチジルイノシトール3−キナーゼのイソインドリノンインヒビター | |
JPH06503349A (ja) | 新規csaids | |
WO1990003789A1 (fr) | DERIVES DE PYRROLO[1,2-a]IMIDAZOLE ET D'IMIDAZO[1,2-a]PYRIDINE ET LEUR EMPLOI COMME INHIBITEURS DE LA VOIE DE LA LIPOXYGENASE 5 | |
US9029392B2 (en) | Quinoline derivatives as kinase inhibitors | |
US5508300A (en) | Dihydro pyrazolopyrroles, compositions and use | |
AU9137591A (en) | Novel csaids | |
US20240043440A1 (en) | Compositions and methods of modulating short-chain dehydrogenase activity | |
JPH05503919A (ja) | 単球および/またはマクロファージによるインターロイキン―1または腫瘍壊死因子生成の抑制 | |
US8536339B2 (en) | AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity | |
KR20020082858A (ko) | 1,5-이치환된-3,4-디히드로-1h-피리미도[4,5-d]피리미딘-2-온 화합물 및 csbp/p38 키나제 매개된 질환의치료시 이들의 용도 | |
JPS62153286A (ja) | 5−リポキシゲナ−ゼ経路の抑制 | |
WO1996012703A1 (fr) | Composes heteroalkyle et heteroarylthioalkyle thiophenoliques inhibiteurs de la 5-lipoxygenase | |
WO2023215803A2 (fr) | Inhibiteurs de cytochrome bd oxydase et leurs utilisations | |
AU2008350293A1 (en) | Antibiotic tetrahydro-beta-carboline derivatives | |
FR2911605A1 (fr) | Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique | |
EP0306300B1 (fr) | Dérivés de pyrrolo[1,2-a]imidazole et imidazo[1,2-a]pyridine et leur utilisation comme inhibiteurs de la 5-lipoxygénase | |
US8853248B2 (en) | (1,2,3-triazolyl)sulfonyl derivatives | |
ZA200205145B (en) | Thienopyridine derivatives, their production and use. | |
JP2017500318A (ja) | 癌および炎症性疾患を処置するための新規化合物 | |
US4542140A (en) | Pyridinyl substituted ketenemercaptal derivatives | |
CA2000258A1 (fr) | Pyrrolo[1,2-a]-imidazole et derives imidazo[1,2-a]-pyridine et usages comme inhibiteurs de la voie de la 5-lipoxygenase | |
JPS62153274A (ja) | 5−リポキシゲナ−ゼ経路の抑制 | |
JPS61205276A (ja) | 複素環式化合物 | |
MXPA00000223A (en) | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |